WS04.4 Guidance on the use of sputum biomarkers to monitor treatment response and act as trial outcomes in cystic fibrosis

A. Lepissier, C. Addy, D. Downey, K. Hayes, I. Sermet

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)S7
JournalJournal of Cystic Fibrosis
Publication statusPublished - 01 Jun 2020

Cite this